CNS Pharmaceuticals(CNSP)
$3.620.00 (0.00%)
CNSP
CNS Pharmaceuticals stock drug pipeline
$3.62
At close:0.00 (0.00%)
Want to see CNSP full AI Analyst Report?
CNS Pharmaceuticals (CNSP) Drug Pipeline
1,098 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Lomustine, Berubicin | Glioblastoma Multiforme, Adult | Phase II | Active Not Recruiting | A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme | Nov 11, 2020 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Lomustine, Berubicin | Phase II | Glioblastoma Multiforme, Adult | Active Not Recruiting | A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme | Nov 11, 2020 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Cns Pharmaceuticals, Inc. (CNSP) have in its pipeline
CNS Pharmaceuticals CNSP is currently developing the following drugs: Lomustine, Berubicin. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
